Divakar Ramakrishnan recently assumed the role of Chief Digital Officer of Eli Lilly and Company to lead enterprise level digital health strategy development and implementation. He also serves as Vice President of Delivery, Devices and Connected Solutions in Lilly Research Laboratories with R&D groups located in both Cambridge MA and Indianapolis, IN. Over the past 4 years, his team has delivered drug delivery and software devices for Lilly’s insulin and biotech portfolio, namely Humalog U200, Kwipen Junior, Humulin U500, Trulicity autoinjector, Taltz autoinjector, Trulicity app and GoDose Titration app. In addition, his team is now focused on next generation technologies spanning drug delivery and software/algorithm enabled connected systems. Divakar joined Lilly in 1998 as a senior scientist in Bioprocess R&D and has since held leadership positions in R&D and Manufacturing. He was also General Manager of Lilly S.A.in Ireland and Vice President at Lilly’s animal health unit, Elanco. Outside Lilly, Divakar has served in two start-ups, namely: Cook Pharmica, LLC and Moderna Therapeutics Inc. Divakar holds a Ph.D. in Chemical Engineering from the Penn State University and an MBA from Harvard Business School.